This federal Project Grant award from the Defense Health Agency supports Albany Medical College's research project titled "TARGETING DENDRITIC CELLS TO PREVENT HBV CHRONIC DISEASE". The $2,464,874 award, which runs from July 1, 2024 to June 30, 2028, is funded through the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420). The project aims to advance medical knowledge and improve healthcare for military service members, veterans, and their families by conducting innovative, high-impact research on hepatitis B virus (HBV) and related chronic diseases. As a leading academic medical institution, Albany Medical College has an extensive history of receiving federal grant and contract awards to support its mission of biomedical research, medical education, and patient care.
Generated 12/10/24, 10:46 AM